mani
natur
lectin
report
antivir
activ
put
forward
potenti
develop
candid
prevent
treat
viral
infect
set
review
survey
literatur
antivir
lectin
review
group
lectin
structur
class
class
sourc
organ
also
detail
carbohydr
specif
report
antivir
activ
review
conclud
brief
discuss
sever
pertin
hurdl
heterolog
protein
must
clear
use
clinic
candid
cite
exampl
studi
report
antivir
lectin
though
clearest
path
current
follow
use
antivir
lectin
antihiv
microbicid
via
topic
mucos
administr
investig
also
found
system
efficaci
acut
infect
follow
subcutan
administr
publish
elsevi
bv
galanthu
nivali
agglutinin
gna
nicotiana
tabacum
agglutinin
lectin
protein
bind
specif
carbohydr
structur
lack
enzymat
activ
mani
lectin
inhibit
replic
virus
interact
viral
envelop
glycoprotein
antivir
lectin
identifi
bacteria
plant
marin
alga
review
discuss
structur
class
lectin
variou
sourc
organ
investig
abil
block
viral
replic
vitro
reduc
sever
ill
prevent
death
virusinfect
laboratori
anim
briefli
summar
structur
basi
antivir
lectin
bind
specif
review
variou
antivir
lectin
sourc
bacteria
terrestri
marin
eukaryot
organ
structur
class
discuss
select
carbohydr
bind
profil
detail
publish
evid
antivir
activ
examin
variou
challeng
topic
system
use
lectin
prevent
treatment
human
viral
infect
includ
bioavail
rout
administr
toxic
immunogen
potenti
cost
conclud
section
discuss
mean
therapeut
util
antivir
lectin
might
improv
molecular
interact
lectin
carbohydr
substrat
highli
specif
recogn
monomer
sugar
well
oligosaccharid
form
part
branch
highmannos
complex
glycan
fig
given
ubiqu
oligosaccharid
posttransl
modif
protein
throughout
order
life
lectin
evolv
play
mani
role
organism
biolog
includ
selfrecognit
protein
fold
cell
movement
adher
lectin
demonstr
potenti
use
histolog
studi
stain
certain
tissu
type
boerwinkel
et
al
diagnost
biosensor
belicki
et
al
well
help
understand
modul
cellular
process
includ
host
defens
infecti
agent
common
rout
viral
recognit
entri
util
glycosyl
envelop
protein
affin
host
cellsurfac
protein
dimitrov
evolutionari
develop
viral
glycosyl
mechan
enhanc
viral
uptak
evad
host
organ
defens
result
coevolut
lectin
specif
nonself
carbohydr
structur
glycosyl
viral
envelop
glycoprotein
sequenc
driven
requir
spontan
mutat
loss
oligosaccharideattach
site
avoid
lectin
recognit
fig
balzarini
et
al
deplet
glycocalyx
surround
envelop
glycoprotein
deleteri
effect
viral
fit
kolchinski
et
al
continu
challeng
enabl
broad
spectrum
viral
suppress
support
studi
lectin
viral
entri
inhibitor
crystal
structur
glycosyl
monom
clade
g
use
coordin
pdbid
render
cartoon
surfac
grey
glycan
render
light
green
red
glycan
posit
render
red
demonstr
affect
antivir
lectin
activ
grft
cvn
svn
b
schemat
highmannos
definit
discuss
purpos
glcnac
mannos
repres
blue
squar
green
circl
respect
branch
highmannos
structur
refer
mannos
mannos
mannos
provid
prophylact
potenti
therapeut
agent
viral
infect
antivir
lectin
interact
predominantli
highmannos
glycan
structur
ad
posttransl
modif
envelop
protein
virus
okeef
et
al
boto
wlodaw
bokesch
et
al
envelop
protein
share
sequenc
homolog
across
envelop
virus
adopt
similar
tertiari
quaternari
structur
perform
equival
function
fig
pancera
et
al
kirchdoerf
et
al
zhao
et
al
use
hiv
exampl
env
protein
complex
compos
transmembran
trimer
extracellular
trimer
fig
pinter
et
al
earl
et
al
envelop
protein
contain
nlink
oligosaccharid
attach
site
defin
consensu
amino
acid
sequenc
enxst
glycosyl
assist
viral
evas
host
immun
system
fig
stewartjon
et
al
env
protein
complex
mediat
attach
entri
target
cell
first
recognit
initi
cascad
conform
reorgan
env
protein
complex
ultim
lead
fusion
viral
envelop
host
cellular
membran
infect
fig
jone
et
al
davenport
et
al
lectin
consid
hiv
entri
inhibitor
interact
glycosyl
moieti
env
protein
complex
prevent
conform
rearrang
requir
viral
fusion
barriento
et
al
antivir
lectin
gener
contain
intern
repeat
within
primari
sequenc
compris
carbohydr
recognit
domain
crd
duplic
bind
domain
provid
mechan
increas
avid
branch
carbohydr
structur
sequenc
ident
lectin
rang
across
genera
greatest
variabl
local
loop
region
contribut
crd
class
sequenc
homolog
found
predominantli
core
structur
compon
lectin
disulfid
bond
present
antivir
lectin
structur
prerequisit
specif
cvn
svn
ah
contain
disulfid
bond
within
singl
domain
andor
domain
lectin
also
known
oligomer
although
also
prerequisit
lectin
form
dimer
trimer
tetram
solut
other
seen
monom
oaa
svn
ah
pcl
tabl
final
certain
member
lectin
discuss
herein
util
strand
exchang
domain
swap
stabil
oligomer
state
ctermin
strand
exchang
seen
bprism
type
ii
fold
domain
swap
seen
cvn
despit
similar
function
specif
recognit
tight
bind
carbohydr
lectin
exhibit
wide
rang
tertiari
structur
fig
tabl
structur
element
orient
crd
space
yield
differ
specif
avid
threedimension
oligosaccharid
structur
antivir
lectin
fold
discuss
review
includ
type
bprism
seen
jacalin
grft
banlec
type
ii
bprism
seen
monocot
deriv
lectin
scl
hha
gna
npl
ricin
b
chainlik
btrefoil
exhibit
ah
cgl
cyanovirin
lectin
fold
seen
cvn
microvirin
hevienlik
seen
uda
well
uniqu
fold
includ
bbarrellik
fold
found
homologu
oaa
strand
antiparallel
bsheet
cona
boomerang
structur
mvl
lectin
gener
classifi
base
glycan
recognit
crd
specif
particular
sugar
ie
mannos
glucos
nacetyl
galactosamin
etc
structur
orient
individu
crd
lectin
add
increas
level
affin
particular
highord
sugar
structur
select
oligosaccharid
specif
antivir
lectin
interact
high
mannos
oligosaccharid
compon
entir
glycan
branch
interact
core
galactos
contain
chitobios
unit
well
branch
fig
tabl
differ
crd
orient
result
lectin
demonstr
xray
crystal
structur
trimer
env
render
ribbon
monom
shown
orang
grey
green
b
hiv
sar
ebola
env
protein
render
fashion
view
orthogon
along
threefold
symmetri
axi
highlight
structur
conserv
virus
c
glycoprotein
render
glycan
red
sphere
model
env
trimer
demonstr
recognit
complex
would
look
like
substanti
decreas
affin
bind
linear
vs
branch
oligomannos
structur
suggest
posit
distanc
orient
sugar
unit
space
import
lectin
specif
analysi
variou
antivir
lectin
crd
cover
review
reveal
mani
interact
predominantli
deriv
hydrogen
bond
protein
backbon
andor
side
chain
atom
oxygen
atom
within
oligosaccharid
jacalinlik
antivir
lectin
util
trio
aromat
residu
provid
interior
wall
crd
instanc
side
chain
tyrosin
tryptophan
may
particip
direct
interact
oligosaccharid
lectin
belong
oaah
famili
conserv
consensu
crd
sequenc
residu
side
chain
backbon
particip
hydrogen
bond
glycan
analysi
frequenc
residu
particip
direct
interact
oligosaccharid
either
back
bone
side
chain
hydrogen
bond
reveal
aspart
glutam
preval
respect
fig
consist
type
lectin
glycan
interact
identifi
nmr
titrat
xray
cocrystal
experi
less
preval
hydrophob
residu
provid
hydrogen
bond
interact
specif
backbon
amid
carbonyl
oxygen
antivir
lectin
detail
appear
work
virus
global
similar
mechan
bind
oligosaccharid
decor
viral
envelop
glycoprotein
via
steric
hindranc
inhibit
viral
fusion
entri
mechan
often
requir
multival
crd
lectin
adequ
potenc
liu
et
al
moulaei
et
al
takahashi
et
al
often
also
reli
crosslink
oligosaccharid
env
oligomer
lectin
barriento
et
al
biochem
basi
lectin
antivir
activ
therefor
appear
tabl
report
antivir
activ
bacteriaderiv
antivir
lectin
sourc
activ
nm
cytotox
refer
actinohivin
longisporum
albid
hiv
chiba
et
al
chiba
et
al
matoba
et
al
cyanovirin
nostoc
ellipsosporum
siv
hcv
influenza
b
ye
boyd
et
al
gustafson
et
al
balzarini
et
al
witvrouw
et
al
alexandr
et
al
barriento
et
al
okeef
et
al
kachko
et
al
hell
et
al
takeb
et
al
tsai
et
al
tsai
et
al
unk
unknown
cvnlike
oligomannos
okeef
et
al
boto
wlodaw
boyd
et
al
gustafson
et
al
yang
et
al
kachko
et
al
hell
et
al
bolmstedt
et
al
shenoy
et
al
bewley
oteroquintero
bewley
kosht
et
al
swanson
et
al
swanson
et
al
gavrovicjankulov
et
al
dimitrijev
et
al
alexandr
et
al
jensen
et
al
mori
et
al
nixon
et
al
ishag
et
al
meuleman
et
al
kouokam
et
al
ferir
et
al
okeef
et
al
emau
et
al
barton
et
al
scl
scilla
campanulata
hiv
mm
unk
wright
et
al
npl
narcissu
pseudonarcissu
unk
marchetti
et
al
balzarini
et
al
weiler
et
al
gna
galanthu
nivali
mgml
mgml
siv
mgml
fiv
mgml
balzarini
et
al
shibuya
et
al
wright
et
al
balzarini
et
al
gordt
et
al
unk
unknown
bourn
et
al
sankaranarayanan
et
al
jeyaprakash
et
al
favero
et
al
corbeau
et
al
corbeau
et
al
hiv
wright
et
al
npl
bii
link
mannos
core
hiv
sauerborn
et
al
marchetti
et
al
balzarini
et
al
weiler
et
al
gna
bii
link
mannos
core
hester
et
al
balzarini
et
al
shibuya
et
al
wright
et
al
hester
wright
wright
hester
hha
man
glcnac
hoorelbek
et
al
chantalat
et
al
hiv
ding
et
al
cona
conalik
sumner
et
al
sawyer
hardman
ainsworth
naismith
et
al
kornfeld
ferri
pashov
et
al
well
establish
detail
suffici
provid
confid
mechan
activ
inde
inhibit
viral
infect
surpris
structur
divers
seen
antivir
lectin
deriv
prokaryot
speci
includ
protein
actinohivin
ah
tanaka
et
al
tabl
protein
fold
group
classifi
btrefoil
cvnlike
oaahlik
btrefoil
type
fold
lectin
fold
share
prokaryot
eukaryot
lectin
discuss
review
furthermor
prokaryot
deriv
lectin
broad
specif
specif
oligosaccharid
structur
member
bind
highmannos
oligosaccharid
core
glcnac
mannos
moieti
actinohivin
ah
isol
actinomycet
longisporum
albid
strain
soil
bacteria
isol
japan
chiba
et
al
residu
protein
molecular
weight
kda
contain
crd
defin
intern
repeat
ah
unusu
among
antihiv
lectin
basic
isoelectr
point
protein
express
proprotein
ntermin
signal
peptid
subsequ
cleav
reveal
matur
residu
lectin
lectin
activ
ic
valu
nm
magi
assay
inhibit
cellcel
fusion
ec
valu
rang
nm
chiba
et
al
xray
crystal
structur
ah
reveal
protein
organ
ricin
bchainlik
btrefoil
bound
crd
locat
second
third
b
strand
carbohydr
bind
site
zhang
et
al
specif
side
chain
hydrogen
bond
trimannos
ligand
sugar
monom
involv
secondari
interact
mediat
water
bridg
kljajic
et
al
muller
et
al
unk
unknown
lectin
xray
crystal
structur
resolv
saccharid
crd
select
possibl
nmr
solut
structur
select
crystal
structur
avail
n
c
termini
repres
sphere
color
blue
red
respect
overal
fold
render
white
residu
particip
crd
highlight
red
sidechain
shown
stick
saccharid
repres
stick
color
accord
atom
highmannos
schemat
display
interact
posit
red
identifi
literatur
grft
engin
monomer
form
lectin
shown
wt
domain
swap
portion
orang
insert
gs
residu
render
black
sphere
cona
dimer
shown
monom
bound
saccharid
white
apo
monom
black
bind
interact
conserv
three
crd
ah
show
tight
specif
bind
glycosyl
k
nm
signific
interact
coreceptor
hoorelbek
et
al
ah
thought
inhibit
viral
entri
bind
highmannos
oligosaccharid
specif
similar
cvn
report
mitogen
hoorelbek
et
al
matoba
et
al
resist
studi
reveal
hiv
becam
resist
ah
contain
mutat
remov
mixtur
differ
nglycosyl
site
includ
typic
bear
high
mannos
oligosaccharid
nglycan
delet
mutat
necessari
reduct
ah
potenc
hoorelbek
et
al
cyanovirin
en
cvn
cyanovirinn
cvn
isol
cyanobacterium
nostoc
ellipsosporum
cultiv
univers
hawaii
boyd
et
al
gustafson
et
al
lectin
focu
much
research
evidenc
publish
paper
protein
contain
residu
molecular
weight
kda
monomer
dimer
crystal
form
solut
protein
adopt
uniqu
fold
compris
tandem
repeat
defin
sequenc
ident
adopt
threestrand
bsheet
bhairpin
exhibit
domainswap
dimer
variou
crystal
solut
structur
boto
wlodaw
yang
et
al
structur
cvn
cocrystal
reveal
extens
interact
outer
branch
highmannos
glycan
specif
side
chain
hydrogen
bond
interact
carbonyl
amid
hydroxyl
mannos
hydrogen
bond
carbonyl
carbonyl
side
chain
respect
amid
extens
antivir
research
shown
cvn
activ
nm
nm
siv
nm
hcv
nm
nm
influenza
b
nm
ebovz
nm
marv
boyd
et
al
balzarini
et
al
witvrouw
et
al
alexandr
et
al
barriento
et
al
okeef
et
al
kachko
et
al
hell
et
al
takeb
et
al
research
carri
reveal
ic
valu
nm
depend
hiv
strain
celltyp
well
lectin
administ
challeng
experi
lectin
discuss
review
cvn
shown
interact
specif
homolog
highmannos
oligosaccharid
k
man
man
two
crd
thought
viral
entri
inhibitor
okeef
et
al
kachko
et
al
hell
et
al
bolmstedt
et
al
shenoy
et
al
bewley
oteroquintero
neutral
cvn
antivir
activ
titrat
increas
concentr
fit
best
twoindepend
site
model
support
stoichiometri
cvn
reveal
ic
nm
bewley
oteroquintero
cvn
complet
inhibit
envinduc
cellcel
fusion
nm
mab
map
studi
indic
cvn
affect
interact
bewley
oteroquintero
vivo
prevent
microbicid
importantli
cvn
produc
cytotox
effect
appli
cvn
topic
gel
rectal
vagin
male
femal
macaqu
challeng
chimer
viru
effect
prevent
shiv
infect
tsai
et
al
tsai
et
al
evalu
cvn
topic
hiv
prevent
continu
recentlyfund
studi
nih
report
constitut
express
cvn
lactobacillu
jensenii
enter
phase
clinic
trial
form
mucocept
quick
dissolv
vagin
suppositori
contain
recombin
live
biotherapeut
product
cohen
vivo
parenter
therapeut
likewis
subcutan
inject
mgkg
cvn
lethal
mous
model
ebolaz
infect
mice
result
immunolog
respons
decreas
mortal
viral
titer
barriento
et
al
taken
togeth
result
indic
cvn
antivir
lectin
shown
potenti
util
prevent
viral
infect
microvirin
mvn
isol
cyanobacterium
microcysti
aeruginosa
kehr
et
al
monomer
lectin
report
molecular
weight
kda
residu
microvirin
adopt
cyanovirinlik
fold
rmsd
acarbon
surpris
given
sequenc
ident
examin
crd
cvn
solut
mvn
solut
structur
reveal
similar
mannos
pose
conserv
bind
pocket
homolog
sugar
protein
interact
side
chain
carbonyl
hydrogen
bond
mannos
monom
extens
interact
second
monom
hydrogen
bond
carbonyl
respect
carboxyl
interact
monom
shahzadulhussan
et
al
bewley
microvirin
test
variou
cell
type
includ
well
clinic
isol
group
env
pseudotyp
tzmbl
cell
rang
ic
valu
nm
shahzadulhussan
et
al
husken
et
al
mvn
activ
clinic
isol
group
pbmc
nm
nm
test
concentr
develop
mvnresist
explor
viru
cell
dilut
concentr
mvn
reveal
mutat
resist
strain
residu
husken
et
al
lectin
specif
bind
fig
frequenc
crd
amino
acid
residu
antivir
lectin
lectin
crd
defin
nmr
titrat
xray
cocrystal
experi
analyz
frequenc
total
residu
lectin
use
analysi
aspart
glutamin
commonli
found
residu
across
lectin
review
hydrophob
residu
particip
hydrogen
bond
carbonyl
andor
amid
atom
tyrosin
tryptophan
particip
back
bone
side
chain
interact
lectin
note
experiment
result
avail
residu
involv
glycan
bind
lectin
exclud
analysi
oligosaccharid
viral
envelop
glycoprotein
prefer
highmannos
glycan
contain
termin
mannos
disaccharid
highest
signal
report
man
arm
man
arm
man
determin
carbohydr
microarray
kehr
et
al
mvn
inhibit
syncytium
format
well
dcsignmedi
viral
bind
cell
husken
et
al
even
though
mvn
display
less
pronounc
mitogen
respons
compar
cvn
freshli
isol
pbmc
two
separ
donor
signific
stimulatori
effect
product
cytokin
gcsf
ifng
tnfa
observ
husken
et
al
protein
also
inhibit
syncytium
format
infect
cell
uninfect
cell
like
cvn
prevent
bind
antihiv
mab
highmannos
albeit
fold
lower
inhibit
bewley
mvn
act
synergist
cvn
shahzadulhussan
et
al
result
support
microvirin
broad
entri
inhibitor
effect
mani
coreceptor
type
well
lab
clinic
isol
group
pbmc
mvl
isol
cyanobacterium
microcysti
viridi
strain
yamaguchi
et
al
homodimer
lectin
kda
consist
residu
contain
intern
repeat
defin
residu
sequenc
ident
william
et
al
apo
holo
crystal
structur
pdbid
reveal
domain
organ
domain
contain
distort
antiparallel
bsheet
wrap
around
residu
ahelix
effect
form
cleft
distal
end
domain
william
et
al
lectin
form
dimer
crystal
solut
extens
interact
buri
solvent
access
surfac
monom
interact
nand
ctermin
domain
dimer
domain
organ
result
cleft
contain
crd
accommod
pentasaccharid
direct
interact
sugar
monom
mvl
report
hcv
activ
nm
nm
respect
william
et
al
kachko
et
al
bewley
et
al
preincub
hcv
prevent
viral
inhibit
mvl
dose
depend
manner
consist
mvl
inhibit
envelop
virus
interact
glycan
glycoprotein
kachko
et
al
bind
affin
mvl
recombin
hcv
glycoprotein
measur
use
biolay
interferometri
reveal
k
kachko
et
al
mvl
thought
inhibit
viral
entri
bind
highmannos
glycan
submicromolar
affin
bewley
et
al
titrat
mvl
support
molecul
mvl
interact
trimer
effect
inhibit
viru
initi
discov
glycan
bind
interact
mvl
also
report
enzymat
activ
repres
novel
bifunct
mode
lectin
famili
shahzadulhussan
et
al
specif
one
crd
capabl
catalyz
enzymat
cleavag
chitotrios
glcnac
mvl
bind
k
mm
respect
time
weaker
author
discov
primari
residu
enabl
enzymat
cleavag
proceed
although
lectin
defin
enzymat
activ
mvl
repres
bifunct
lectin
discuss
review
svn
isol
cyanobacterium
scytonema
varium
bokesch
et
al
monomer
lectin
kda
compris
residu
organ
intern
repeat
sequenc
ident
overal
fold
svn
loos
secondari
structur
contain
cystein
interdomain
disulfid
bridg
per
intern
repeat
intradomain
disulfid
linkag
per
molecul
result
total
cystin
moulaei
et
al
mcfeeter
et
al
crd
differ
affin
tetramannos
scytovirin
domain
higher
affin
research
effort
focus
gener
monom
reveal
bulk
svn
activ
deriv
specif
xiong
et
al
three
structur
present
protein
databank
pdb
none
contain
oligomannos
crd
howev
nhsqc
oligosaccharid
titrat
studi
identifi
chemic
shift
perturb
residu
residu
ration
decreas
affin
oligomoannos
result
increas
electroneg
residu
substitut
asparagin
aspart
monomer
lectin
test
varieti
virus
includ
ebola
hcv
marburg
viru
marv
rang
ic
nm
bokesch
et
al
alexandr
et
al
xiong
et
al
xiong
et
al
jensen
et
al
garrison
et
al
subnanomolar
activ
seen
includ
coreceptor
variant
well
svn
interact
envelop
protein
highmannos
glycan
contain
tetramannos
k
mm
mm
mcfeeter
et
al
western
blot
analysi
support
svn
interact
glycosyl
zebov
garrison
et
al
likewis
svn
also
shown
interact
specif
highmannos
glycan
envelop
glycoprotein
hcv
takeb
et
al
find
support
svn
inhibit
viral
entri
interact
glycan
viral
envelop
protein
svn
subcutan
inject
balbc
mice
infect
ebola
zebov
marv
mgkgday
four
dose
reveal
sign
cytotox
surviv
rate
highlight
therapeut
potenti
lectin
garrison
et
al
ic
svn
zebov
marv
nm
respect
inject
svn
bioavail
balbc
mice
show
mark
decreas
baselin
level
within
h
inject
thu
requir
inject
per
day
maintain
effect
antivir
serum
concentr
greatli
complic
contain
efficaci
studi
surviv
rate
past
day
svn
treatment
h
h
day
viral
challeng
indic
efficaci
system
treatment
mammalian
system
despit
short
halflif
inject
svn
potenc
rang
sensit
virus
absenc
report
cytotox
earn
particular
antivir
lectin
high
potenti
therapeut
statu
though
svn
display
good
efficaci
protect
mice
zebov
challeng
associ
short
halflif
make
develop
agent
depend
modif
protein
could
extend
serum
halflif
ie
pegylationmodif
polyethylen
glycol
crystal
structur
oaah
compris
bstrand
fold
bbarrellik
architectur
mannos
bind
site
local
loop
nmr
solut
structur
bound
free
state
reveal
dynam
loop
crd
carneiro
et
al
koharudin
et
al
crd
oscillatoria
agardhii
agglutinin
homolog
oaah
antivir
lectin
consensu
sequenc
includ
three
region
specif
defin
use
oaa
number
residu
nqwgg
gxrx
qxv
gegpigf
region
loop
locat
bstrand
present
antivir
lectin
mention
homologu
high
sequenc
ident
intern
repeat
member
contain
repeat
oaah
lectin
discuss
review
ic
nm
tzmbl
cell
interact
specif
core
mannos
oscillatoria
agardhii
agglutinin
oaa
isol
cyanobacterium
oscillatoria
agardhii
strain
sato
et
al
lectin
molecular
weight
kda
consist
residu
make
two
tandem
repeat
defin
residu
sequenc
ident
sato
et
al
examin
apo
holo
crystal
structur
reveal
dimer
consensu
oaahlectin
fold
littl
conform
chang
upon
carbohydr
bind
nmr
titrat
oaa
reveal
two
crd
differ
affin
mannos
higher
affin
estim
k
mm
koharudin
et
al
oaa
report
ec
nm
use
coreceptor
strain
lab
ic
nm
tzmbl
cell
sato
et
al
sato
et
al
koharudin
et
al
lectin
specif
interact
highmannosetyp
nglycan
mannos
disaccharid
reveal
nmr
titrat
experi
dissoci
constant
oaa
heptasaccharid
highmannos
type
nglycan
determin
centrifug
ultrafiltrationhplc
fluoresc
label
oligosaccharid
reveal
lectin
possess
two
carbohydr
bind
site
per
molecul
consist
tandem
repeat
primari
sequenc
oaa
also
interact
recombin
glycoprotein
k
determin
surfac
plasmon
reson
tremend
affin
heptasaccharid
mannos
glycoprotein
modest
ec
highlight
import
aspect
lectin
base
antivir
mechan
action
e
name
strong
interact
substrat
glycan
necessarili
correl
effect
viral
inhibit
least
case
oaa
pseudomona
fluorescen
agglutinin
pfa
identifi
sequenc
search
oaa
homologu
koharudin
et
al
hypothet
protein
sequenc
ident
similar
oaa
primari
sequenc
tandem
repeat
pfa
lectin
select
recombin
express
e
coli
biochem
biolog
structur
character
pfa
kda
protein
compris
residu
sequenc
repeat
crystal
structur
reveal
tertiari
structur
homolog
oaahlectin
fold
lectin
activ
tzmbl
cell
ic
nm
nmr
titrat
experi
pfa
mannopentos
result
fulli
occupi
protein
sugar
molar
ratio
koharudin
et
al
consist
oaa
reson
perturb
earlier
titrat
experi
residu
support
differ
affin
mannopentos
substrat
two
bind
domain
similar
pfa
myxococcu
xanthu
hemeagglutinin
mbha
identifi
sequenc
search
oaa
homologu
koharudin
et
al
hypothet
protein
sequenc
ident
similar
oaa
primari
sequenc
tandem
repeat
mbha
lectin
select
recombin
express
e
coli
biochem
biolog
structur
character
mbha
kda
protein
consist
residu
sequenc
repeat
lectin
monomer
solut
xray
crystal
structur
reveal
oaahlectin
fold
interestingli
sequenc
repeat
orient
flip
respect
sequenc
repeat
contrast
orient
two
protein
crystallograph
pack
pfa
lectin
activ
tzmbl
cell
ic
nm
koharudin
et
al
nmr
titrat
experi
mbha
mannopentos
result
fulli
occupi
molar
ratio
similar
oaahlectin
member
reson
attribut
perturb
earlier
nmr
titrat
experi
residu
suggest
differ
affin
mannopentos
substrat
four
bind
site
result
indic
initi
interact
glycan
lectin
take
place
follow
subsequ
bind
suggest
primari
oligosaccharid
recognit
dictat
bind
domain
burkholderia
oklahomensi
agglutinin
boa
isol
proteobacterium
burkholideria
oklahomensi
whitley
et
al
residu
protein
contain
ntermin
residu
tail
present
oaah
member
like
mbha
primari
sequenc
boa
compris
tandem
repeat
xray
crystal
structur
confirm
dimer
oaahlectin
fold
four
crd
sequenc
repeat
share
sequenc
ident
residu
superposit
individu
monom
onto
canon
oaa
structur
result
ca
furthermor
conform
crd
bound
oligomannos
conserv
small
conform
heterogen
observ
loop
similar
oaah
member
boa
activ
tzmbl
cell
ic
rang
nm
whitley
et
al
dissoci
constant
estim
use
n
hsqc
titrat
experi
boa
mannopentos
report
mm
four
crd
bound
due
natur
experi
individu
crd
k
could
assign
averag
ic
compar
oaah
member
plant
eukaryot
antivir
lectin
also
rang
structur
divers
classifi
bprism
type
bprism
type
ii
concanavalinlik
heveinlik
fold
fig
tabl
eukaryot
antivir
lectin
contain
tandem
repeat
within
primari
sequenc
exist
monomer
higher
multimer
state
except
hevienlik
class
compris
larg
bsheet
eukaryot
lectin
also
rang
glycan
bind
specif
includ
glcnac
glcnac
man
core
mannos
highmannos
galnac
specif
well
tabl
lectin
jacalin
isol
jackfruit
seed
artocarpu
integrifolia
roqu
barreira
camposneto
lectin
exist
homotetram
solut
monomer
molecular
weight
kda
import
contribut
lectin
antivir
lectin
discuss
review
wealth
structur
inform
publish
date
bourn
et
al
sankaranarayanan
et
al
jeyaprakash
et
al
twelv
pdb
entri
repres
first
structur
describ
type
bprism
fold
commonli
refer
jacalinlik
lectin
fold
type
bprism
fold
threefold
symmetri
domain
compris
fourstrand
greek
key
motif
protein
posttransl
modifi
proteolyt
cleavag
first
residu
nterminu
result
heavi
jacalin
chain
light
residu
peptid
b
chain
crystal
structur
achain
form
portion
crd
carbonyl
hbond
hydroxyl
methylagalactos
sankaranarayanan
et
al
crd
larg
compris
hydrophob
aromat
residu
exhibit
hydrogen
bond
interact
galactos
amid
carboxyl
jacalin
exhibit
submicromolar
antihiv
activ
ec
nm
depend
assay
cell
type
favero
et
al
jacalin
distinct
antivir
lectin
discuss
review
mechan
action
like
deriv
interact
lectin
glycoprotein
rather
interact
glycan
decor
host
cell
surfac
favero
et
al
corbeau
et
al
corbeau
et
al
initi
thought
jacalin
specif
bound
galb
galnac
subsequ
spr
crystallograph
studi
reveal
jacalin
promiscu
saccharid
bind
crd
accommod
galnac
glcnac
murnac
deriv
glucos
mannos
galactos
albeit
much
higher
concentr
bourn
et
al
corbeau
et
al
corbeau
et
al
furthermor
residu
peptid
deriv
jacalin
homolog
portion
sequenc
exhibit
mild
inhibitori
effect
hiv
mm
favero
et
al
jacalin
lectin
discuss
review
thought
prefer
glycan
banlec
lectin
isol
banana
musa
acumin
exist
homodim
molecular
weight
kda
kosht
et
al
lectin
exhibit
jacalinlik
lectin
fold
rmsd
acarbon
superpos
jacalin
structur
fig
singh
et
al
meagher
et
al
examin
crd
xray
crystal
structur
banlec
jacalin
respect
reveal
similar
pose
omethylmannos
well
overal
organ
crd
loop
specif
mannos
interact
amid
well
carboxyl
howev
banlec
exhibit
domain
swap
proteolyt
cleavag
ntermin
residu
seen
jacalin
lectin
contain
crd
per
monom
potent
activ
tzmbl
indic
cell
rang
ic
valu
nm
nm
pseudotyp
meagher
et
al
swanson
et
al
banlec
interact
directli
glycoprotein
highmannos
result
block
viral
entri
decreas
level
strongstop
product
earli
viral
transcript
swanson
et
al
antivir
activ
rbanlec
report
ec
valu
nm
across
variou
hcv
genotyp
ec
valu
mgml
mgml
viru
mdck
cell
respect
swanson
et
al
approxim
surviv
rate
low
dose
mg
wild
type
banlec
rbanlec
potent
tcell
mitogen
swanson
et
al
gavrovicjankulov
et
al
rbanlec
immunostimulatori
effect
form
complex
superfici
mucu
jejunum
dimitrijev
et
al
rbanlec
also
stabl
mous
gastrointestin
tract
vivo
lectin
interact
glycosyl
group
mucos
surfac
effort
reduc
mitogen
lectin
exhibit
strong
tcell
mitogen
respons
research
conduct
mutat
protein
reduc
mitogen
preserv
virucid
activ
swanson
et
al
effect
mutat
result
substanti
decreas
mitogenc
maintain
antivir
effect
swanson
et
al
interestingli
mutat
posit
near
crd
yet
littl
effect
virucid
activ
substanti
alter
mannos
pose
crystallo
align
wt
banlec
structur
result
rootmeansquar
deviat
ca
posit
slight
perturb
backbon
residu
indic
strong
structur
conserv
remain
protein
backbon
fig
reposit
loop
result
residu
ca
closer
cb
closer
crd
mutant
structur
allow
addit
hydrogen
bond
dimannos
hydroxyl
methodolog
reduc
mitogen
retain
structur
integr
provid
rout
potenti
develop
antivir
lectinbas
therapeut
due
potenc
hiv
low
mitogen
recombin
mutant
banlec
potenti
therapeut
import
respect
mani
antivir
lectin
discuss
review
griffithsin
grft
isol
aqueou
extract
red
alga
griffithsia
sp
collect
eastern
shore
chatham
island
new
zealand
mori
et
al
lectin
kda
compris
residu
exist
homodim
solut
extens
biolog
structur
biophys
research
conduct
extrem
potent
antivir
grft
adopt
jacalinlik
bprism
type
fold
rmsd
acarbon
contain
ntermin
bstrand
exchang
form
stabl
dimer
use
pdbid
unligand
grft
jacalin
fig
ziolkowska
et
al
like
type
bprism
fold
lectin
griffithsin
crd
contain
three
aromat
residu
tyrosin
residu
form
interior
bind
site
side
chain
amid
hydrogen
bond
mannos
oxygen
seen
crystal
structur
complex
mannobios
extens
interact
seen
cocryst
structur
monomer
grft
nonamannosid
termin
mannos
unit
across
three
bind
site
crd
defin
residu
fig
third
bind
site
mannos
donat
symmetri
relat
molecul
crystal
moulaei
et
al
griffithsin
initi
identifi
screen
ec
nm
laboratori
strain
primari
isol
mori
et
al
grft
also
test
numer
virus
includ
subtyp
nm
nm
hcv
nm
mm
sar
nm
variou
avian
cov
subtyp
nm
bovin
coronaviru
nm
avian
infecti
bronchiti
viru
nm
mous
hepat
viru
nm
puffinosi
coronaviru
nm
human
coronaviru
hcov
mutant
nm
japanes
enceph
viru
jev
nm
simian
immunodefici
viru
nm
chimer
simian
human
immunodefici
viru
nm
ebola
viru
result
soon
publish
greatest
potenc
hcov
rang
ic
nm
alexandr
et
al
jensen
et
al
mori
et
al
nixon
et
al
ishag
et
al
meuleman
et
al
kouokam
et
al
ferir
et
al
okeef
et
al
emau
et
al
vivo
parenter
therapeut
lectin
test
number
vivo
model
hcv
grft
system
distribut
throughout
sera
plasma
subcutan
inject
activ
preserv
sera
test
followup
cellbas
antivir
assay
barton
et
al
minim
toxic
observ
rang
singl
repeat
sc
daili
dose
grft
two
rodent
speci
rgrft
plant
recombin
inflammatori
irrit
rabbit
vagin
irrit
model
support
therapeut
potenti
lectin
okeef
et
al
subcutan
administ
grft
also
efficaci
hcv
mousehuman
chimer
liver
model
readili
bioavail
plasma
mgml
day
slow
reduct
mgml
day
takeb
et
al
grft
well
toler
system
treat
mice
daili
dose
mgkg
final
intraperiton
administ
grft
mgkg
prior
viral
present
complet
inhibit
jev
infect
mortal
mous
model
ishag
et
al
vivo
prevent
microbicid
grft
also
block
celltocel
transmiss
protect
mice
genit
herp
singl
dose
intravagin
applic
grft
gel
nixon
et
al
grft
gel
cytotox
prevent
mucos
respons
intranas
administr
grft
mgkg
protect
sarscov
lethal
mous
model
pulmonari
infect
prevent
weight
loss
improv
lung
histopatholog
reduc
lung
tissu
viru
titer
ziolkowska
et
al
okeef
et
al
accord
nih
report
clinic
trial
anticip
activ
agent
grft
formul
rectal
microbicid
gel
prevent
viral
entri
hiv
type
well
hcv
project
number
palmer
grft
exhibit
potent
virucid
activ
rang
envelop
virus
lectin
also
stabl
elev
temperatur
broad
rang
ph
amen
largescal
prepar
recombin
system
okeef
et
al
research
effort
gener
monomer
form
grft
mgrft
result
decreas
antivir
potenc
nm
suggest
oligomer
state
distanc
crd
strongli
influenc
virucid
activ
fig
moulaei
et
al
monomer
form
lectin
particip
domain
swap
first
two
bstrand
engin
insert
glyser
posit
local
random
coil
strand
fig
engin
tandemer
mgrft
mgrft
link
variabl
length
linker
result
antihiv
activ
ec
pm
respect
moulaei
et
al
examin
antihiv
activ
variou
subtyp
b
c
strain
mgrft
tandem
reveal
better
global
antihiv
activ
median
ic
valu
nm
respect
compar
mgrft
wtgrft
isotherm
titrat
calorimetri
bind
studi
reveal
tandem
bind
glycosyl
nm
affin
slightli
better
grft
almost
order
magnitud
better
mgrft
alon
tandemer
repres
potent
antivir
lectin
discuss
herein
vivo
character
make
outstand
candid
clinic
use
topic
microbicid
sc
engin
monomer
mgrft
repres
cartoon
highlight
lack
domainswap
crd
color
red
pdbid
use
show
crd
gs
insert
repres
black
sphere
unswap
portion
orang
c
close
crd
residu
make
activ
site
red
glycan
stick
represent
therapeut
lectin
adopt
monocot
consensu
fold
contain
three
antiparallel
bsheet
arrang
approxim
symmetri
result
bprism
type
ii
fold
crd
per
monom
hester
et
al
bprism
ii
fold
lectin
contain
conserv
hydrophob
core
paramount
structur
conserv
mannos
bind
sequenc
qxdxnxvxi
wright
monocot
consensu
fold
lectin
discuss
review
specif
link
mannos
tabl
member
class
lectin
biosynthes
residu
preprotein
posttransl
cleav
n
c
termini
result
matur
residu
proprotein
particip
ctermin
strand
exchang
scilla
campanulata
lectin
scl
isol
bulb
spanish
bluebel
monomer
molecular
weight
kda
contain
residu
exist
tetram
solut
lectin
report
moder
antihiv
activ
ec
valu
mm
respect
wright
et
al
protein
adopt
monocot
consensu
fold
publish
crystal
structur
report
mannos
specif
higher
prefer
mannotrios
determin
inhibit
studi
mm
wright
et
al
although
crystal
structur
contain
mannos
align
scl
npl
gna
primari
sequenc
reveal
conserv
monocot
consensu
crd
signatur
narcissu
pseudonarcissu
lectin
npl
also
known
narcissu
pseudonarcissu
agglutinin
isol
daffodil
bulb
lectin
consist
residu
monomer
molecular
weight
kda
solut
report
form
dimer
trimer
tetramer
oligom
crystallograph
sax
structur
sizeexclus
experi
support
tetramer
assembl
sauerborn
et
al
npl
monom
crd
fourth
low
affin
crd
adopt
monocot
consensu
fold
residu
particip
strand
exchang
ref
mannos
bind
crd
npl
interact
side
chain
conserv
across
three
crd
lectin
report
antisiv
activ
ec
mgml
nm
lesser
extent
antihsv
antirabi
antirubella
activ
mic
mm
respect
marchetti
et
al
balzarini
et
al
weiler
et
al
literatur
support
antivir
activ
deriv
specif
interact
link
mannos
consist
lectin
famili
marchetti
et
al
balzarini
et
al
weiler
et
al
galanthu
nivali
agglutinin
gna
isol
bulb
snowdrop
galanthu
nivali
shibuya
et
al
lectin
monomer
molecular
weight
kda
adopt
tetramer
state
solut
wright
et
al
crystal
structur
reveal
protein
adopt
monocot
consensu
fold
conserv
crd
residu
compar
oligosaccharid
bound
npl
structur
wright
hester
lectin
report
anti
siv
felin
immunodefici
viru
fiv
nonnucleosid
revers
transcriptas
inhibitor
nnrti
resist
lamivudin
zidouvudin
piresist
rang
ec
valu
mgml
balzarini
et
al
balzarini
et
al
solut
bind
studi
reveal
lectin
prefer
oligosaccharid
contain
link
mannos
decreas
affin
amylos
dextran
glycogen
shibuya
et
al
like
antivir
lectin
previous
discuss
antivir
activ
thought
deriv
specif
interact
mannos
glycoprotein
furthermor
gna
illicit
mitogen
respons
pbmc
cultur
mgml
intraven
administ
gna
nmri
mice
mgkg
bolu
inject
result
measur
toxic
effect
balzarini
et
al
hippeastrum
hybrid
agglutinin
hha
isol
bulb
amarylli
hippeastrum
hybrid
protein
kda
exist
tetram
solut
lectin
report
siv
fiv
nnrtiresist
lamivudin
zidouvudin
piresist
rang
ec
valu
mgml
balzarini
et
al
surfac
plasmon
reson
studi
confirm
lectin
interact
specif
viral
envelop
protein
dissoci
constant
nm
monomer
wt
trimer
respect
hoorelbek
et
al
although
pdbid
exist
particular
protein
crystal
structur
hha
report
chantalat
et
al
structur
solv
molecular
replac
use
coordin
monocot
consensu
fold
adopt
lectin
gna
support
hha
adopt
monocot
consensu
fold
similar
gna
hha
illicit
mitogen
respons
pbmc
cultur
mgml
intraven
administ
gna
nmri
mice
mgkg
bolu
inject
result
measur
toxic
effect
balzarini
et
al
polygonatum
cyrtonema
lectin
pcl
isol
rhizom
tradit
chines
medicin
herb
p
cyrtonema
hau
kda
protein
contain
residu
exist
dimer
solut
xray
crystal
structur
resolv
bound
dimannosid
interact
monocot
crd
consensu
sequenc
support
lectin
antihiv
activ
stem
interact
glycan
andor
ding
et
al
pcl
report
activ
ec
valu
mgml
make
pcl
potent
monocot
consensu
fold
lectin
discuss
review
mn
bind
concanavalin
cona
origin
isol
jackbean
canavalia
ensiformi
sumner
et
al
cona
belong
legum
lectin
famili
monomer
weight
lectin
kda
exist
tetram
solut
sawyer
structur
present
pdb
reveal
similar
fold
antiparallel
bstrand
adopt
bsheet
compris
bstrand
also
bind
ca
mn
hardman
ainsworth
interestingli
one
crd
defin
per
monom
total
crd
present
intact
tetram
mannos
bind
crd
interact
amid
hydrogen
bond
well
carboxyl
side
chain
naismith
et
al
cona
report
activ
ec
mgml
antihsv
activ
ic
nm
witvrouw
et
al
okada
kim
cona
bind
requir
glcnac
termin
amannos
residu
well
branch
mannos
suggest
similar
inclus
interact
mvl
kornfeld
ferri
cona
report
interact
nonspecif
variou
glycoform
suggest
lectin
less
sensit
mutat
glycosyl
locat
envelop
protein
monoclon
antibodi
pashov
et
al
urtica
dioica
agglutinin
uda
urtica
dioica
agglutinin
uda
isol
sting
nettl
urtica
dioica
monomer
molecular
weight
kda
shibuya
et
al
wagner
et
al
lectin
two
intern
repeat
sequenc
ident
includ
residu
includ
residu
uda
adopt
heveinlik
domain
contain
disulfid
bond
per
domain
crd
per
domain
crystal
structur
bound
tetrasaccharid
glcnac
reveal
carbonyl
hydrogen
bond
hydroxyl
hydrophob
interact
sugar
hydroxyl
hydrogen
bond
acet
carbonyl
hydrogen
bond
glcnac
hydrophob
interact
hydrogen
bond
hydroxyl
harata
muraki
saul
et
al
uda
crd
specif
interact
sugar
use
cocrystal
experi
repres
core
glycan
bind
specif
seen
lectin
mention
review
antivir
activ
report
cytomegaloviru
cmv
respiratori
syncyti
viru
rsv
influenza
sarscov
rang
ic
valu
mm
balzarini
et
al
keyaert
et
al
uda
specif
interact
oligom
glcnac
presum
core
glycan
homolog
envelop
protein
vivo
parenter
therapeut
uda
test
sarscov
infect
balbc
mice
demonstr
mgkgday
significantli
protect
mice
lethal
infect
reduc
lung
patholog
score
protect
weight
loss
reduc
viral
lung
titer
day
et
al
therefor
uda
repres
moder
activ
antivir
lectin
increas
therapeut
util
due
lack
mitogen
respons
perhap
effort
increas
specif
test
envelop
virus
increas
util
lectin
myrianthu
holstii
lectin
mhl
isol
root
african
plant
myrianthu
holstii
charan
et
al
kda
lectin
activ
infect
cemss
cell
ec
nm
exhibit
glcnac
specif
although
structur
current
avail
protein
thought
adopt
fold
similar
uda
due
strong
sequenc
ident
similar
glycan
specif
nicotiana
tabacum
agglutinin
nictaba
e
structur
unknown
nictaba
first
identifi
leav
nicotiana
tabacum
var
samsun
nn
respons
treatment
jasmon
insect
infest
chen
et
al
kda
lectin
adopt
dimer
solut
kda
report
antivir
activ
nm
hsv
nm
influenza
ab
nm
rsv
nm
found
inact
nonenvelop
virus
gordt
et
al
nictaba
specif
interact
glcnac
oligom
highmannos
type
glycan
surfac
plasmon
reson
reveal
k
respect
nictaba
affect
bind
mab
suggest
altern
interact
compar
hha
uda
lectin
inhibit
syncytium
format
dcsign
direct
transmiss
tlymphocyt
median
cytotox
concentr
nictaba
greater
mgml
variou
celllin
despit
abund
put
homolog
sequenc
mani
flower
plant
genom
structur
inform
current
exist
nictaba
consid
prototyp
ubiquit
famili
lectin
belong
plant
chen
et
al
marin
deriv
eukaryot
antivir
lectin
littl
structur
inform
avail
specif
cgl
deriv
marin
mussel
crenomytilu
grayanu
marin
lectin
publish
structur
btrefoil
antivir
activ
structur
class
glycan
specif
summar
tabl
lectin
marin
worm
chaetopteru
variopedatu
cvl
e
structur
unknown
cvl
isol
marin
worm
chaetopteru
variopedatu
mikheyskaya
et
al
kda
protein
report
inhibit
syncytium
format
ec
nm
elicit
cytopath
effect
cell
concentr
test
mm
wang
et
al
carbohydr
specif
cvl
assess
inhibit
cvl
mediat
hemagglutin
monosaccharid
oligosaccharid
glycoprotein
result
hemagglutinin
inhibit
mannos
monosaccharid
rather
saccharid
contain
galactos
serpula
vermiculari
lectin
isol
sea
worm
serpula
vermiculari
molchanova
et
al
lukyanov
et
al
kda
homotetramer
protein
carbohydr
prefer
mannos
protein
report
activ
ec
mgml
kda
homotetramer
protein
monomer
weight
kd
carbohydr
content
calcul
phenolsulfur
acid
method
reveal
molecular
weight
deriv
carbohydr
suggest
lectin
glycoprotein
shown
prefer
glcnac
indic
inhibit
hemagglutin
variou
saccharid
block
upregul
viral
antigen
inhibit
infect
ec
mgml
respect
crenomytilu
grayanu
lectin
cgl
isol
sea
mussel
crenomytilu
grayanu
collect
great
bay
sea
japan
belogortseva
et
al
protein
contain
residu
molecular
weight
kda
three
intern
repeat
similar
crystal
structur
reveal
cgl
adopt
btrefoil
type
fold
three
crd
conserv
sequenc
h
yk
ggvhdh
ra
jakob
et
al
liao
et
al
protein
dimer
crystallo
sizeexclus
chromatographi
cgl
shown
interact
mucintyp
receptor
report
carbohydr
prefer
galnac
gal
belogortseva
et
al
furtak
et
al
nmr
titrat
experi
result
calcul
k
galactos
galactosamin
crd
mm
respect
crd
prefer
galactosamin
prefer
galactos
liao
et
al
modest
b
activ
report
ec
mgml
lukyanov
et
al
bacteri
agglutin
fungal
hyphal
growth
suppress
also
report
cgl
inhibit
increas
concentr
galactos
kovalchuk
et
al
chikalovet
et
al
final
cgl
report
low
anticanc
activ
breast
cancer
mtt
assay
mgml
liao
et
al
cgl
might
gener
cytotox
due
mild
activ
myriad
organ
didemnum
ternatanum
lectin
dtl
didemnum
ternatanum
lectina
dtla
isol
ascidian
didemnum
ternatanum
belogortseva
et
al
dtl
report
homotrimer
molecular
weight
kda
reduc
molecular
weight
kda
hemagglutin
activ
inhibit
addit
glcnac
chitobios
desialyl
glycoprotein
belogortseva
et
al
dlta
molecular
weight
kda
capabl
form
highmolecular
aggreg
lectin
report
interact
glcnac
galnac
suggest
two
independ
bind
site
alter
specif
differ
sugar
lukyanov
et
al
dtl
dtla
report
iii
b
activ
ec
nm
respect
dtl
inhibit
antigen
synthesi
mgml
exhibit
cytotox
cell
mgml
dtla
less
effect
hiv
dtl
approxim
order
magnitud
gerardia
savaglia
lectin
gsl
isol
marin
coral
savaglia
savaglia
report
heterodimer
molecular
weight
kda
kljajic
et
al
residu
protein
rich
acid
amino
acid
pi
contain
cystein
identifi
amino
acid
analysi
lectin
inhibit
nuclear
mrna
transloc
vitro
report
activ
nm
mitogen
concentr
muller
et
al
gsl
inhibit
syncytia
format
human
lymphocyt
system
shown
interact
glycan
loss
activ
observ
presenc
dmannos
support
gsl
interact
highmannos
glycan
primari
sequenc
structur
inform
avail
challeng
clinic
use
heterolog
lectin
human
antivir
prophylaxi
therapi
deriv
difficulti
inhibit
viral
entri
pharmacolog
hurdl
administ
foreign
protein
human
system
whether
lectin
describ
eventu
use
clinic
depend
number
physiolog
factor
discuss
point
develop
antivir
lectin
pursu
clinic
antistd
primarili
hiv
microbicid
via
mucos
administr
addit
system
efficaci
acut
infect
demonstr
subcutan
administr
much
less
preclin
data
gener
use
antivir
lectin
manner
factor
describ
relat
specif
system
use
eg
bioavail
other
import
administr
rout
eg
toxicityimmunogen
afford
first
hurdl
clinic
util
antivir
lectin
assess
bioavail
follow
administr
protein
assum
lectin
abl
oral
administ
would
surviv
digest
enzym
studi
assess
system
bioavail
lectin
two
lectin
assess
cvn
grft
cvn
found
biolog
avail
follow
subcutan
inject
mice
barriento
et
al
dose
mgkgday
toler
bioavail
cvn
assess
context
studi
evalu
system
efficaci
ebola
zair
eboz
cvn
shown
delay
mean
time
death
treat
anim
sever
day
anim
challeng
intraperiton
inject
eboz
combin
result
indic
cvn
bioavail
retain
activ
follow
subcutan
inject
larger
sampl
pertin
data
bioavail
grft
initi
studi
grft
concentr
stabil
biolog
fluid
grft
shown
stabl
either
buffer
solut
ph
cervic
vagin
lavag
fluid
week
either
c
c
loss
activ
emau
et
al
evalu
physiolog
stabil
grft
reveal
grft
resist
degrad
human
proteas
experi
show
greatest
resist
proteas
degrad
antimicrobi
peptid
test
moncla
et
al
elastas
famili
human
proteas
found
moder
degrad
grft
studi
directli
measur
bioavail
distribut
grft
follow
subcutan
inject
mice
guinea
pig
also
report
barton
et
al
shown
grft
fulli
biolog
avail
mice
follow
singl
subcutan
inject
mgkg
plasma
level
reach
nm
day
reduc
nm
day
second
studi
mice
inject
subcutan
mgkg
day
day
show
steadi
increas
grft
plasma
level
reach
peak
nm
day
persist
level
nm
one
week
cessat
administr
grft
concentr
sera
guinea
pig
similar
mgkgday
treatment
reach
level
nm
day
reduc
nm
day
day
cessat
treatment
studi
also
found
grft
distribut
tissu
kidney
liver
spleen
tissu
show
level
approxim
mgg
tissu
respect
note
plasma
sampl
taken
test
anim
show
grft
retain
antihiv
activ
plasma
follow
subcutan
administr
day
addit
report
efficaci
grft
svn
includ
activ
hepat
c
follow
subcutan
inject
takeb
et
al
meuleman
et
al
grft
japanes
enceph
viru
follow
intraperiton
inject
ishag
et
al
svn
also
report
bioavail
plasma
level
mgml
display
vivo
efficaci
eboz
follow
subcutan
inject
mice
garrison
et
al
report
provid
evid
antivir
lectin
bioavail
activ
vivo
major
concern
clinic
agent
chanc
toxic
unrel
target
activ
agent
though
antivir
lectin
target
oligosaccharid
present
viral
envelop
glycoprotein
oligosaccharid
synthes
attach
host
cell
enzym
mean
also
present
human
cell
potenti
side
effect
system
use
lectin
could
aris
wellestablish
abil
lectin
agglutin
cell
nicolson
therefor
incumb
upon
research
test
antivir
lectin
abil
agglutin
haemopoeit
cell
prior
propos
system
use
toxic
could
aris
acut
immunolog
respons
administr
foreign
protein
anaphylaxi
baker
et
al
immunogen
perhap
greatest
concern
clinic
use
foreign
protein
human
hand
current
exampl
heterolog
protein
use
human
clinic
treatment
exist
includ
cone
snail
peptid
ziconotid
chronic
pain
wallac
et
al
gila
monster
saliva
peptid
exenatid
system
administ
type
ii
diabet
wysham
et
al
promin
microbi
product
botulinum
toxin
brin
protein
use
success
clinic
year
accept
risk
profil
give
encourag
endeavor
discov
addit
biolog
activ
protein
peptid
antivir
lectin
discuss
review
mani
assess
vivo
either
toxic
immunogen
concanavalin
identifi
clearli
caus
agent
acut
liver
injuri
mice
tieg
et
al
due
bind
sinusoid
endotheli
cell
caus
cell
attack
tcell
knoll
et
al
ultim
lead
cascad
damag
liver
death
mice
antivir
lectin
report
unaccept
toxic
includ
uda
wga
npl
jacalin
clear
potenti
advers
effect
necessit
new
antivir
lectin
test
agglutin
immunogen
final
compon
potenti
advers
effect
antivir
lectin
relat
directli
potenti
use
antihiv
agent
statu
foreign
protein
human
system
heterolog
protein
potenti
stimulatori
immun
system
often
demonstr
abil
activ
tcell
pbmc
immun
cell
activ
stimul
increas
amount
hiv
target
cell
near
site
administr
topic
system
increas
level
target
cell
advers
effect
actual
increas
likelihood
hiv
infect
concern
advers
effect
rais
sever
lectin
includ
cona
cvn
balzarini
et
al
antivir
lectin
due
proteinac
natur
report
biologicallyavail
follow
oral
administr
necessit
administr
altern
rout
report
antivir
efficaci
antivir
protein
includ
administ
topic
okeef
et
al
tsai
et
al
administ
system
either
subcutan
barriento
et
al
barton
et
al
intraperiton
kouokam
et
al
inject
intranas
administr
prevent
respiratori
infect
okeef
et
al
smee
et
al
addit
administr
method
includ
dispar
mechan
vagin
deliveri
geneticallyengin
lactobacilli
secret
cvn
direct
suppositori
administr
vagin
yamamoto
et
al
feed
yogurt
provid
rectal
administr
li
et
al
varieti
administr
method
indic
robust
effort
far
expend
insur
potent
antivir
lectin
reach
site
action
intact
final
concern
clinic
util
antivir
protein
cost
virus
lectin
put
forward
potenti
clinic
agent
either
emerg
infecti
agent
ebola
sar
cov
japanes
enceph
microbicid
agent
act
sexual
transmit
virus
hiv
hsv
econom
realiti
particular
util
requir
antivir
protein
produc
reason
cost
one
consid
societi
impact
current
hiv
epidem
predominantli
minim
health
resourc
patient
popul
need
low
cost
product
strategi
clear
address
need
protein
grft
cvn
produc
genet
engin
plant
includ
tobacco
okeef
et
al
sexton
et
al
soy
okeef
et
al
rice
vamvaka
et
al
vamvaka
et
al
cost
advantag
largescal
plantbas
product
offer
opportun
effect
bring
antivir
protein
clinic
chen
davi
mani
clinic
use
small
molecul
natur
product
antivir
protein
potenti
improv
chang
structur
render
suitabl
clinic
develop
structur
inform
avail
protein
enabl
ration
design
mutant
protein
improv
capabl
case
design
potent
analog
demonstr
grft
tandem
engin
allow
conform
freedom
crd
result
fold
improv
antihiv
activ
enhanc
activ
grftresist
strain
hiv
moulaei
et
al
grft
tandem
abl
show
similar
activ
hiv
strain
lack
oligosaccharid
posit
subtyp
c
env
glycoprotein
render
viru
resist
monomer
wt
grft
form
fig
alexandr
et
al
modif
affect
immunogen
antivir
protein
includ
modif
cvn
polyethylen
glycol
peg
reduc
immunogen
increas
halflif
serum
zapp
et
al
genet
engin
banlec
reduc
presenc
antigen
epitop
swanson
et
al
swanson
et
al
reduc
immunogen
mutat
banlec
thought
mediat
mitogen
impart
decreas
affin
complex
sugar
hybrid
lectin
also
produc
pfa
oaa
render
protein
opa
improv
activ
koharudin
et
al
modif
structur
produc
oblig
monomer
moulaei
et
al
dimer
takahashi
et
al
protein
effort
improv
clinic
potenti
signific
research
potenti
use
modif
necessari
truli
develop
agent
human
use
